PolyPeptide Group AG (SWX:PPGN)
Switzerland
· Delayed Price · Currency is CHF 36.80
+1.50 (4.25%)
Apr 29, 2026, 11:52 AM CET
PolyPeptide Group AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Operating Revenue | 389.33 | 336.79 | 320.37 | 280.98 | 282.13 | Upgrade
|
| Revenue | 389.33 | 336.79 | 320.37 | 280.98 | 282.13 | Upgrade
|
| Revenue Growth (YoY) | 15.60% | 5.13% | 14.02% | -0.41% | 25.78% | Upgrade
|
| Cost of Revenue | 324.04 | 299.31 | 315.6 | 228.99 | 182.43 | Upgrade
|
| Gross Profit | 65.29 | 37.49 | 4.77 | 51.99 | 99.7 | Upgrade
|
| Selling, General & Admin | 55.64 | 44.25 | 41.54 | 40.63 | 32.5 | Upgrade
|
| Research & Development | 2.28 | 1.1 | 1.47 | 1.24 | 1.41 | Upgrade
|
| Other Operating Expenses | -1.11 | -1.9 | -4.4 | -2.41 | -1.61 | Upgrade
|
| Operating Expenses | 56.82 | 43.44 | 38.6 | 39.46 | 32.3 | Upgrade
|
| Operating Income | 8.47 | -5.95 | -33.83 | 12.53 | 67.4 | Upgrade
|
| Interest Expense | -17.2 | -13.85 | -5.62 | -2.09 | -2.82 | Upgrade
|
| Interest & Investment Income | 1.82 | 0.59 | 0.05 | 0.01 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | -12.27 | 6.18 | -14.5 | -1.63 | -1.87 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.02 | -3.63 | -1.63 | -1.25 | -0.17 | Upgrade
|
| EBT Excluding Unusual Items | -20.2 | -16.66 | -55.52 | 7.57 | 62.55 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.44 | - | - | - | - | Upgrade
|
| Asset Writedown | -1.3 | -1.49 | -2.72 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -2.71 | Upgrade
|
| Pretax Income | -20.06 | -18.15 | -58.24 | 7.57 | 59.85 | Upgrade
|
| Income Tax Expense | 1.11 | 1.42 | -6.8 | -0.2 | 12.59 | Upgrade
|
| Net Income | -21.17 | -19.56 | -51.44 | 7.77 | 47.26 | Upgrade
|
| Net Income to Common | -21.17 | -19.56 | -51.44 | 7.77 | 47.26 | Upgrade
|
| Net Income Growth | - | - | - | -83.56% | 50.81% | Upgrade
|
| Shares Outstanding (Basic) | 33 | 33 | 33 | 33 | 32 | Upgrade
|
| Shares Outstanding (Diluted) | 33 | 33 | 33 | 33 | 32 | Upgrade
|
| Shares Change (YoY) | 0.09% | 0.10% | -0.11% | 2.74% | 7.08% | Upgrade
|
| EPS (Basic) | -0.64 | -0.59 | -1.56 | 0.24 | 1.47 | Upgrade
|
| EPS (Diluted) | -0.64 | -0.59 | -1.56 | 0.24 | 1.47 | Upgrade
|
| EPS Growth | - | - | - | -83.98% | 41.35% | Upgrade
|
| Free Cash Flow | -30.24 | 3.65 | -16.41 | -69.64 | -16.61 | Upgrade
|
| Free Cash Flow Per Share | -0.92 | 0.11 | -0.50 | -2.11 | -0.52 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.289 | Upgrade
|
| Gross Margin | 16.77% | 11.13% | 1.49% | 18.50% | 35.34% | Upgrade
|
| Operating Margin | 2.18% | -1.77% | -10.56% | 4.46% | 23.89% | Upgrade
|
| Profit Margin | -5.44% | -5.81% | -16.06% | 2.76% | 16.75% | Upgrade
|
| Free Cash Flow Margin | -7.77% | 1.08% | -5.12% | -24.79% | -5.89% | Upgrade
|
| EBITDA | 38.1 | 18.28 | -12.31 | 33.05 | 83.46 | Upgrade
|
| EBITDA Margin | 9.79% | 5.43% | -3.84% | 11.76% | 29.58% | Upgrade
|
| D&A For EBITDA | 29.63 | 24.23 | 21.52 | 20.53 | 16.06 | Upgrade
|
| EBIT | 8.47 | -5.95 | -33.83 | 12.53 | 67.4 | Upgrade
|
| EBIT Margin | 2.18% | -1.77% | -10.56% | 4.46% | 23.89% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 21.04% | Upgrade
|
| Revenue as Reported | 391.95 | 338.77 | 324.85 | 283.46 | 286.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.